Top of this page
Skip navigation, go straight to the content
Study Results Lay Summaries
Lay summaries of clinical study results are intended to share the findings of clinical research with study participants, patients and the public in easy-to-understand language. UCB currently provides these summaries for:
- Pivotal studies or studies that were key for the approval of medicines
- Pivotal studies for medicines where clinical development has been terminated globally.
- Plans are underway to expand lay summary development to include additional studies and to provide these summaries in additional languages in the future.
Lay summaries are also included with other study information via the Compounds drop-down menu on the Clinical Studies Index page.
Brivaracetam
Cimzia® (certolizumab pegol)
Keppra® (levetiracetam)
Neupro® (rotigotine)
